iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.75+0.04 (+5.86%)
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
iBio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
iBio's price to sales ratio was 459.1× on Nov 11, 2026, against 40.0× a year earlier. Over the last 5 years it ranged from 2.1× to 459.1×, with a median of 78.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 459.1× | +380.9 |
| 2025 | Dec 31, 2025 | 78.2× | −42.7 |
| 2024 | Dec 31, 2024 | 120.9× | +83.0 |
| 2023 | Dec 29, 2023 | 37.9× | +35.8 |
| 2022 | Dec 30, 2022 | 2.1× | −48.4 |
| 2021 | Dec 31, 2021 | 50.5× | −47.1 |
| 2020 | Dec 31, 2020 | 97.6× | +94.7 |
| 2019 | Dec 31, 2019 | 2.9× | −34.6 |
| 2018 | Dec 31, 2018 | 37.5× | −6.4 |
| 2017 | Dec 29, 2017 | 43.9× | +5.2 |
| 2016 | Dec 30, 2016 | 38.6× | +2.3 |
| 2015 | Dec 31, 2015 | 36.3× | −9.1 |
| 2014 | Dec 31, 2014 | 45.5× | +14.2 |
| 2013 | Dec 31, 2013 | 31.2× | +9.2 |
| 2012 | Dec 31, 2012 | 22.0× | −103.1 |
| 2011 | Oct 31, 2011 | 125.1× | – |
See a number that looks wrong?